Medical Mass

Medical Mass represents a contemporary cultivar engineered for therapeutic applications, featuring elevated cannabidiol content paired with minimal tetrahydrocannabinol levels. This balanced profile delivers substantial health benefits while minimizing intoxicating sensations. The genetics reflect a 60% indica-dominant hybrid structure (40% sativa) created by crossing Critical Mass with a CBD-concentrated strain, resulting in a remarkably functional plant.

Growers of all skill levels will appreciate this variety's adaptability to both controlled indoor environments and outdoor gardens. Plants typically reach 60–100 cm tall and demonstrate strong productivity, yielding approximately 500–550 g/m² when cultivated indoors. The compact stature makes it particularly suitable for limited growing areas.

Completion of the flowering phase occurs within 7–8 weeks, with outdoor harvests typically concluding by late September. The consumed product presents a rich sensory profile dominated by sweet undertones complemented by honey and skunk characteristics, producing a profound calming sensation. Medical Mass stands out as an especially valuable option for therapeutic applications due to its restrained growth pattern, straightforward cultivation requirements, accelerated maturation timeline, and clinical-grade potency.